Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging.

Radiology ◽  
1993 ◽  
Vol 186 (2) ◽  
pp. 495-501 ◽  
Author(s):  
Y Yamashita ◽  
M Harada ◽  
T Sawada ◽  
M Takahashi ◽  
K Miyazaki ◽  
...  
2006 ◽  
Vol 63 (12) ◽  
pp. 1006-1010 ◽  
Author(s):  
Zorica Stanojevic ◽  
Biljana Djordjevic

Background/Aim. Endometrial carcinoma is the most common malignant neoplasm of the female genital tract in developed countries. Endometrioid carcinoma represents about three-fourths of all endometrial carcinoma. The aim of this study was to examine pathologic parameters, age, and the 5-year survival of the patients with FIGO stage I endometrial carcinoma of endometrioid type and to assess the prognostic utility of age, depth of myometrial invasion, hystologic type (endometrioid or variant), histologic grade, nuclear grade, and lymph-vascular space invasion. Methods. Age, pathologic parameters, and survival data were retrospectively collected on 236 patients with FIGO stage I endometrial carcinoma of endometrioid type. All the patients underwent hysterectomy between 1996 and 2000 and follow-up until December 2005. Results. A total of 236 patients (mean age 58.0, range 40?79) were analyzed. During the 5-year period of follow-up, 59 (25.0%) patents died from the disease. An univariate analysis revealed that age, depth of myometrial invasion, histologic grade, nuclear grade, and lymph-vascular space invasion were associated significantly with the 5-year survival of the patients. A multivariate analysis revealed that age, lymph-vascular space invasion, and depth of myometrial invasion were associated significantly with the 5-year survival. Conclusion. Age, lymph-vascular space invasion, and depth of myometrial invasion are independent prognostic parameters for the 5-year survival of the patients with FIGO stage I endometrial carcinoma of endometrioid type.


Radiology ◽  
1995 ◽  
Vol 194 (2) ◽  
pp. 567-572 ◽  
Author(s):  
L M Scoutt ◽  
S M McCarthy ◽  
S D Flynn ◽  
R C Lange ◽  
F Long ◽  
...  

1987 ◽  
Vol 27 (2) ◽  
pp. 180-188 ◽  
Author(s):  
Setsuko K. Chambers ◽  
Daniel S. Kapp ◽  
Richard E. Peschel ◽  
Roberta Lawrence ◽  
Maria Merino ◽  
...  

1994 ◽  
Vol 31 (4) ◽  
pp. 731
Author(s):  
Byung Hee Lee ◽  
Kie Hwan Kim ◽  
Kyung Hee Lee ◽  
Jin Joo Lee ◽  
Soo Yil Chin ◽  
...  

2021 ◽  
Vol 162 ◽  
pp. S267-S268 ◽  
Author(s):  
Dimitrios Nasioudis ◽  
Erin McMinn ◽  
Emily Ko ◽  
Ashley Haggerty ◽  
Lori Cory ◽  
...  

1983 ◽  
Vol 69 (1) ◽  
pp. 65-67 ◽  
Author(s):  
Giuseppe De Palo ◽  
Giovanni Battista Spatti ◽  
Gaetano Bandieramonte ◽  
Luciano Luciani

A pilot study with adjuvant hormone therapy in FIGO stage I endometrial carcinoma with myometrial invasion was carried out. All patients received total abdominal hysterectomy and bilateral salpingo-oophorectomy plus complementary radium therapy on the vaginal stump. After the conventional treatment, patients were randomly allocated to adjuvant hormone therapy or no further treatment. Hormone therapy consisted of gestonorone caproate (17α-hydroxy-19-norpregn-4-en 3,20 dione caproate) administered i.m. at the dose of 200 mg/week for 1 year. Of the 62 patients who entered the study, 51 were considered evaluable (24 with adjuvant hormone therapy and 27 with no further treatment). Five patients had a relapse: four of these were in the group with no further treatment. Actuarial relapse-free survival analysis at 5 years was 95.7% in the group of adjuvant-treated patients and 82.8% in the control group. Although there is no statistical significance, adjuvant therapy appears to result in an increase in relapse-free survival in the group of patients with deep myometrial invasion and undifferentiated carcinoma. Further studies are necessary to assess the effectiveness of hormone adjuvant treatment in FIGO stage I endometrial carcinoma with myometrial invasion.


1995 ◽  
Vol 74 (9) ◽  
pp. 723-728 ◽  
Author(s):  
Giuseppe Gioele Garzetti ◽  
Andrea Ciavattini ◽  
Gaia Goteri ◽  
Carlo Romanini

Sign in / Sign up

Export Citation Format

Share Document